Frank Reiher

Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium–derived factor

Olga V. Volpert, Tetiana Zaichuk, Wei Zhou et al. · Nature Medicine · 2002 · 421 citations

Inflammation, Thrombosis, Inducer-stimulated Fas Targets +15

Thrombospondin‐1, vascular endothelial growth factor and fibroblast growth factor‐2 are key functional regulators of angiogenesis in the prostate

Jennifer A. Doll, Frank Reiher, Susan E. Crawford et al. · The Prostate · 2001 · 135 citations

Inhibition of tumor growth by systemic treatment with thrombospondin‐1 peptide mimetics

Frank Reiher, Olga V. Volpert, Benilde Jiménez et al. · International Journal of Cancer · 2002 · 126 citations · Full text

Adjuvant Cisplatin Plus Methotrexate Versus Methotrexate, Vinblastine, Epirubicin, and Cisplatin in Locally Advanced Bladder Cancer: Results of a Randomized, Multicenter, Phase III Trial (AUO-AB 05/95)

Jan Lehmann, Margitta Retz, Christina Wiemers et al. · Journal of Clinical Oncology · 2005 · 119 citations

In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects

Stéphanie Filleur, Olga V. Volpert, Armelle Degeorges et al. · Genes & Development · 2001 · 107 citations · Full text